Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT06972407
What this trial is testing

The Effect of rs7903146 Genotype on Islet GLP-1 Production in Humans

Who this might be right for
Genetic PredispositionType2diabetes
Mayo Clinic 80
Testing effectiveness (Phase 2)UnknownNCT06500299
What this trial is testing

Evaluate the Safety and Efficacy of HDM1002 Tablets in Overweight and Obese Adults

Who this might be right for
Overweight and Obesity
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 180
Not applicableLooking for participantsNCT07480109
What this trial is testing

Increased Dietary Protein Intake During GLP-1 Medication Use (in Middle-aged Women With Overweight/Obesity)

Who this might be right for
ObesityWomen (Between 30 to 60 Years Old)
University of Texas at Austin 75
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07509112
What this trial is testing

Semaglutide for Treatment of People With Methamphetamine Use Disorder: the SHIFT Study

Who this might be right for
Methamphetamine Use Disorder
Kirby Institute 40
Large-scale testing (Phase 3)Study completedNCT06489457
What this trial is testing

The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in Men With Type 2 Diabetes Mellitus and Obesity

Who this might be right for
Type 2 Diabetes MellitusObesityFunctional Hypogonadism
University Medical Centre Ljubljana 25
Testing effectiveness (Phase 2)Study completedNCT06712836
What this trial is testing

A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight or Obesity
Pfizer 239
Not applicableLooking for participantsNCT07625202
What this trial is testing

Creatine Supplementation During GLP-1a Therapy

Who this might be right for
Sarcopenia
University of Saskatchewan 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07825857
What this trial is testing

Randomized Controlled Trial of Tirzepatide for Methamphetamine Use Disorder

Who this might be right for
Methamphetamine Use Disorder
University of Texas Southwestern Medical Center 228
Testing effectiveness (Phase 2)Looking for participantsNCT06582875
What this trial is testing

Glucagon-Like Peptide-1 Receptor Agonist in ADPKD

Who this might be right for
Autosomal Dominant Polycystic KidneyObesity
University of Colorado, Denver 126
Post-approval studies (Phase 4)Study completedNCT02050074
What this trial is testing

The Role of Metformin and Colesevelam in Human GLP-1 Secretion

Who this might be right for
Type 2 Diabetes
University Hospital, Gentofte, Copenhagen 12
Early research (Phase 1)Not Yet RecruitingNCT07782359
What this trial is testing

Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving Lorlatinib

Who this might be right for
Lung Cancer
University of Chicago 30
Testing effectiveness (Phase 2)UnknownNCT04615910
What this trial is testing

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

Who this might be right for
Diabetes Mellitus
Radboud University Medical Center 30
Not applicableStudy completedNCT05854979
What this trial is testing

Effects of GLP-1 Agonists on Gastric Volume

Who this might be right for
DiabetesGastric Content AspirationGlucagon-like Peptide 1+1 more
Medical University of South Carolina 210
Testing effectiveness (Phase 2)Study completedNCT02975297
What this trial is testing

Exenatide Once Weekly for Smoking Cessation

Who this might be right for
Smoking Cessation
The University of Texas Health Science Center, Houston 84
Very early researchUnknownNCT06217848
What this trial is testing

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Who this might be right for
PanhypopituitarismCraniopharyngiomaHypothalamic Obesity
Seoul National University Hospital 50
Post-approval studies (Phase 4)Looking for participantsNCT07718126
What this trial is testing

Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)

Who this might be right for
Metabolic Dysfunction-Associated SteatohepatitisHepatic SteatosisLiving Liver Donors
West China Hospital 60
Post-approval studies (Phase 4)Study completedNCT02832999
What this trial is testing

Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Yaounde Central Hospital 14
Early research (Phase 1)Study completedNCT05835752
What this trial is testing

The Safety, Tolerability and Pharmacokinetic Study of RAY1225

Who this might be right for
ObeseHealthy
Guangdong Raynovent Biotech Co., Ltd 68
Not applicableUnknownNCT02372526
What this trial is testing

The Effect of Different Macronutrients on Gastrointestinal Hormone Secretion After Gastric Bypass Operation

Who this might be right for
Bariatric Surgery (Gastric Bypass)Overweight
Kirstine Nyvold Bojsen-Moeller 18
Not applicableStudy completedNCT03923114
What this trial is testing

Imaging Pituitary ActiVation by Exendin

Who this might be right for
Diabetes Mellitus, Type 2
Radboud University Medical Center 20
Next Page